Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin.
Andriulli A, Di Marco V, Margaglione M, Ippolito AM, Fattovich G, Smedile A, Valvano MR, Calvaruso V, Gioffreda D, Milella M, Morisco F, Felder M, Brancaccio G, Fasano M, Gatti P, Tundo P, Barone M, Cozzolongo R, Angelico M, D'Andrea G, Andriulli N, Abate ML, Mazzella G, Gaeta GB, Craxi A, Santantonio T. Andriulli A, et al. Among authors: mazzella g. J Hepatol. 2014 Jan;60(1):16-21. doi: 10.1016/j.jhep.2013.07.040. Epub 2013 Aug 20. J Hepatol. 2014. PMID: 23973930 Free article.
A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C.
Fattovich G, Zagni I, Minola E, Felder M, Rovere P, Carlotto A, Suppressa S, Miracolo A, Paternoster C, Rizzo C, Rossini A, Benedetti P, Capanni M, Ferrara C, Costa P, Bertin T, Pantalena M, Lomonaco L, Scattolini C, Mazzella G, Giusti M, Boccia S, Milani S, Marin R, Lisa Ribero M, Tagger A. Fattovich G, et al. Among authors: mazzella g. J Hepatol. 2003 Nov;39(5):843-9. doi: 10.1016/s0168-8278(03)00391-x. J Hepatol. 2003. PMID: 14568269 Clinical Trial.
HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome.
Andriulli A, Morisco F, Ippolito AM, Di Marco V, Valvano MR, Angelico M, Fattovich G, Granata R, Smedile A, Milella M, Felder M, Gaeta GB, Gatti P, Fasano M, Mazzella G, Santantonio T. Andriulli A, et al. Among authors: mazzella g. Hepatol Int. 2015 Jan;9(1):52-7. doi: 10.1007/s12072-014-9556-2. Epub 2014 Aug 13. Hepatol Int. 2015. PMID: 25788379 Free article.
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study.
Bruno S, Stroffolini T, Colombo M, Bollani S, Benvegnù L, Mazzella G, Ascione A, Santantonio T, Piccinino F, Andreone P, Mangia A, Gaeta GB, Persico M, Fagiuoli S, Almasio PL; Italian Association of the Study of the Liver Disease (AISF). Bruno S, et al. Among authors: mazzella g. Hepatology. 2007 Mar;45(3):579-87. doi: 10.1002/hep.21492. Hepatology. 2007. PMID: 17326216
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV.
Karampatou A, Han X, Kondili LA, Taliani G, Ciancio A, Morisco F, Critelli RM, Baraldi E, Bernabucci V, Troshina G, Guarino M, Tagliavini S, D'Ambrosio F, Bristot L, Turco L, Rosato S, Vella S, Trenti T, Neri I, La Marca A, Manthena S, Goldstein AS, Bruno S, Bao Y, Gonzalez YS, Villa E; PITER framework investigators; PITER Investigators. Karampatou A, et al. J Hepatol. 2017 Sep 5:S0168-8278(17)32259-6. doi: 10.1016/j.jhep.2017.08.019. Online ahead of print. J Hepatol. 2017. PMID: 28882581 Free article.
The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.
Flisiak R, Feinman SV, Jablkowski M, Horban A, Kryczka W, Pawlowska M, Heathcote JE, Mazzella G, Vandelli C, Nicolas-Métral V, Grosgurin P, Liz JS, Scalfaro P, Porchet H, Crabbé R. Flisiak R, et al. Among authors: mazzella g. Hepatology. 2009 May;49(5):1460-8. doi: 10.1002/hep.22835. Hepatology. 2009. PMID: 19353740 Clinical Trial.
Efficacy of ursodeoxycholic acid in association with alpha-interferon for chronic hepatitis C in alpha-interferon non-responder patients.
Fabbri C, Marchetto S, Pezzoli A, Accogli E, Fusaroli P, Azzaroli F, Jaboli MF, Mazzeo C, Montagnani M, Festi D, Roda E, Mazzella G. Fabbri C, et al. Among authors: mazzella g. Eur J Gastroenterol Hepatol. 2000 May;12(5):511-5. doi: 10.1097/00042737-200012050-00006. Eur J Gastroenterol Hepatol. 2000. PMID: 10833093 Clinical Trial.
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation.
Lodato F, Berardi S, Gramenzi A, Mazzella G, Lenzi M, Morelli MC, Tame MR, Piscaglia F, Andreone P; Bologna Liver Transplantation Group (BLTG); Ballardini G, Bernardi M, Bianchi FB, Biselli M, Bolondi L, Cescon M, Colecchia A, D'Errico A, Del Gaudio M, Ercolani G, Grazi GL, Grigioni W, Lorenzini S, Pinna AD, Ravaioli M, Roda E, Sama C, Vivarelli M. Lodato F, et al. Among authors: mazzella g. Aliment Pharmacol Ther. 2008 Aug 15;28(4):450-7. doi: 10.1111/j.1365-2036.2008.03761.x. Epub 2008 Jun 11. Aliment Pharmacol Ther. 2008. PMID: 18549463 Free article. Clinical Trial.
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation.
Tamè M, Buonfiglioli F, Del Gaudio M, Lisotti A, Cecinato P, Colecchia A, Azzaroli F, D'Errico A, Arena R, Calvanese C, Quarneti C, Ballardini G, Pinna AD, Mazzella G. Tamè M, et al. Among authors: mazzella g. World J Gastroenterol. 2013 Aug 28;19(32):5278-85. doi: 10.3748/wjg.v19.i32.5278. World J Gastroenterol. 2013. PMID: 23983430 Free PMC article.
229 results